Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ONXX -- Ignore unavailable to you. Want to Upgrade?

To: Tom Hua who wrote (413)	8/2/2000 8:09:32 PM
From: Paul Kern	Read Replies (1) \| Respond to of 810

Do I put AXYX on my watch list and sign up for new alerts so I can catch it on the way up like ONXX or is it a dead, overhyped dog? MCOM is a good one. I found it through a friends recommendation before the first rollout of it's R2 serviceand sold it on the big run-up. The shorts absolutely trashed it back to it's original level and now I've bought it again expecting a slow steady ride up because the technology is good and the company has real earnings. I'll watch ONXX and decided whether it's a buy or not after I see how far it falls but I'll keep it on my watch list and watch for the next spike. If you like small biotechs, ATIS is near final approval for lab grown skin for the treatment of diabetic foot ulcers. The idiots didn't listen to the FDA, didn't follow the protocols, and didn't provide what the agency wanted or it would be selling the skin right now.Sometimes I think the scientists should stick to science and these companies should hire business people and compliance officers with solid industry experience. Paul